Tempus AI Launches Next-Gen Agentic Platform to Accelerate Oncology Research
Tempus AI Inc. (NASDAQ:TEM), 31 Mayıs'ta Lens'in yeni nesil agentic AI platformunu lanç etti. Bu platform, **onkoloji ilaç geliştirme** süreçlerini hı
Tempus AI Inc. (NASDAQ:TEM) launched the next generation of Lens, an agentic AI platform designed to accelerate oncology drug development. By integrating Tempus' massive library of longitudinal real-world data, oncology foundation models, and computational infrastructure, the platform provides an end-to-end environment for research and trial design. It is already being used by 19 of the top 20 global biopharma companies.
The platform uses specialized "co-scientist" agents that allow users to propose complex biological hypotheses in plain language and receive targeted analysis plans. Once a plan is approved, these agents execute code-backed analyses against over 8.5 million de-identified patient records, delivering robust results in minutes. This process significantly reduces the time and manual expertise previously required for such tasks.
Tempus AI Inc. (NASDAQ:TEM) is a healthcare technology company that uses AI to advance precision medicine. It achieves this through its massive libraries of clinical and genomic data. Pharmaceutical companies use their products to improve drug discovery processes while physicians use them to personalize treatments for their patients.
While we acknowledge the potential of TEM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
In conclusion, Tempus AI's next-gen agentic platform is a significant step forward in oncology research. Its contributions to the healthcare sector and drug development processes may play a crucial role in the future.
Related News & Analysis
View All →
Years’ Buckwheat Recall: A Silent Threat to Pet Health and Brand Trust

Harvard’s AI Clones: The New Pitch Platform for Start‑ups

Treasury's Short‑Term Bill Play: Reshaping Long‑Term Rates Without Printing Money

Gen Z Skips Mortgages for Digital Portfolios: The New Wealth Paradigm

AI Power Struggle: OpenAI‑Anthropic Alliance, China’s Open‑Weight Models, and the Application Layer’s New Balance

Iran-China Oil Flow Dries Up: US Blockade Sends Shockwaves Through Markets
Latest Market News
All News →
Bitcoin & Ether Crush Bears in Squeeze‑Led Rally, Musk’s X Shifts to Stablecoin Payments
Istanbul Airport Retains Title as Europe’s Busiest Hub with 1,665 Daily Flights

Years’ Buckwheat Recall: A Silent Threat to Pet Health and Brand Trust

Harvard’s AI Clones: The New Pitch Platform for Start‑ups
TCMB Drops Regulation on Physical Gold in Financial System
